Zoetis Announces Appointment of Roman Trawicki as President of Global Manufacturing and Supply
November 24 2014 - 9:00AM
Business Wire
Trawicki joins Zoetis from GE Healthcare and
brings more than 20 years of experience in healthcare manufacturing
and operations to the role
Zoetis Inc. (NYSE:ZTS) today announced the appointment of Roman
Trawicki as President of its Global Manufacturing and Supply
organization.
With more than 20 years of broad, international experience in
healthcare manufacturing and operations, Mr. Trawicki will oversee
the company’s global manufacturing and supply network that produces
more than 300 animal health product lines for the company. As the
world leader in animal health, Zoetis utilizes a network of 27
internal manufacturing facilities and about 200 external suppliers
to manufacture and deliver its products to veterinarians and
livestock producers in more than 120 countries.
Mr. Trawicki will join Zoetis from GE Healthcare, where he has
been General Manager of Global Supply Chain for Medical Diagnostics
focusing on diagnostics, injectable contrast media and nuclear
medicines. In that role, he has managed 2,500 colleagues across the
world and overseen 16 manufacturing sites. During his career he has
gained extensive global leadership experience in lean
manufacturing, supply and operations from additional roles at GE
Healthcare, Coloplast and Smith & Nephew.
“I am confident that Zoetis will benefit from Roman’s experience
and leadership, along with his manufacturing, operations, and
continuous improvement expertise,” said Kristin Peck, Executive
Vice President and Group President for Zoetis, with responsibility
for manufacturing and supply. “He brings an outside perspective
that will strengthen our manufacturing organization and serve us
well as we capitalize on advances inside and outside of Zoetis to
optimize our network for the future. As always, our collective goal
remains to deliver high quality, reliable supply at competitive
costs, and drive profitable results for Zoetis.”
Mr. Trawicki earned his bachelor’s degree in Mechanical
Engineering from University of Hertfordshire, U.K. in 1986, and
worked in engineering roles for Ford Motor Company, Black &
Decker Corporation and Cummins Engine Company before moving into
the healthcare sector at Smith & Nephew in 1992.
Mr. Trawicki will join the company on January 1, 2015, replacing
Carolyn Hawver, current president of the Global Manufacturing and
Supply organization. Ms. Hawver had announced her retirement plans
earlier in the year, and the appointment of Mr. Trawicki completes
that leadership transition. He will be based at the company’s
location in Zaventem, Belgium, and report to Ms. Peck.
About Zoetis
Zoetis (zô-EH-tis) is the leading animal health company,
dedicated to supporting its customers and their businesses.
Building on more than 60 years of experience in animal health,
Zoetis discovers, develops, manufactures and markets veterinary
vaccines and medicines, complemented by diagnostic products and
genetic tests and supported by a range of services. In 2013, the
company generated annual revenue of $4.6 billion. With
approximately 9,800 employees worldwide at the beginning of 2014,
Zoetis has a local presence in approximately 70 countries,
including 27 manufacturing facilities in 10 countries. Its products
serve veterinarians, livestock producers and people who raise and
care for farm and companion animals in 120 countries. For
more information, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This
press release contains forward-looking statements, which reflect
the current views of Zoetis with respect to business plans or
prospects, future operating or financial performance, expectations
regarding products, future use of cash and dividend payments, and
other future events. These statements are not guarantees of future
performance or actions. Forward-looking statements are subject to
risks and uncertainties. If one or more of these risks or
uncertainties materialize, or if management's underlying
assumptions prove to be incorrect, actual results may differ
materially from those contemplated by a forward-looking statement.
Forward-looking statements speak only as of the date on which they
are made. Zoetis expressly disclaims any obligation to update or
revise any forward-looking statement, whether as a result of new
information, future events or otherwise. A further list and
description of risks, uncertainties and other matters can be found
in our Annual Report on Form 10-K for the fiscal year ended
December 31, 2013, including in the sections thereof captioned
“Forward-Looking Information and Factors That May Affect Future
Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on
Form 10-Q and in our Current Reports on Form 8-K. These filings and
subsequent filings are available online at www.sec.gov,
www.zoetis.com, or on request from Zoetis.
Media Contacts:Bill Price, 1-973-443-2742
(o)william.price@zoetis.comorElinore White, 1-973-443-2835
(o)elinore.y.white@zoetis.comorInvestor Contact:John
O'Connor, 1-973-822-7088
(o)john.oconnor@zoetis.com
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024